Bioengineered Vascular Biomaterials

Competitive advantage

Fundamental and multidisciplinary expertise in:

• Synthetic and natural biomaterials
• Blood vessel cell surface and extracellular matrix molecules
• Recombinant protein expression
• Biochemical, biophysical and cell-based functional assays
• In vivo models

Impact

• Developing next generation biomaterials that interface with the body to direct blood vessel and tissue repair

Successful outcomes

• IP portfolio in methods to produce signalling molecules
• Preclinical testing for novel vascular graft coating
• Preclinical testing for diabetic wound healing
• Coatings for prolonged platelet storage

Capabilities and facilities

• State-of-the-art preclinical biomaterial and biological molecule development and testing laboratories encompassing in vitro and in vivo analyses

Our partners

• Synedgen Inc
• TriCol Biomedical
• Diabetes Australia
• Australian Red Cross Blood Service